These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9327444)

  • 1. Simultaneous quantification of an enantiomer and the racemic compound of ibuprofen by X-ray powder diffractometry.
    Phadnis NV; Suryanarayanan R
    Pharm Res; 1997 Sep; 14(9):1176-80. PubMed ID: 9327444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of the optical purity of ibuprofen using X-ray powder diffraction.
    Stahly GP; McKenzie AT; Andres MC; Russell CA; Byrn SR; Johnson P
    J Pharm Sci; 1997 Aug; 86(8):970-1. PubMed ID: 9269877
    [No Abstract]   [Full Text] [Related]  

  • 3. Physicochemical stability of solid dispersions of enantiomeric or racemic ibuprofen in stearic acid.
    Corvis Y; Négrier P; Espeau P
    J Pharm Sci; 2011 Dec; 100(12):5235-43. PubMed ID: 21905027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissolution enhancement by bio-inspired mesocrystals: the study of racemic (R,S)-(+/-)-sodium ibuprofen dihydrate.
    Lee T; Zhang CW
    Pharm Res; 2008 Jul; 25(7):1563-71. PubMed ID: 18302008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-ray powder diffractometric method for quantitation of crystalline drug in microparticulate systems. I. Microspheres.
    Dash AK; Khin-Khin A; Suryanarayanan R
    J Pharm Sci; 2002 Apr; 91(4):983-90. PubMed ID: 11948537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereospecific formulation and characterization of sustained release ibuprofen microspheres.
    Janjikhel RK; Adeyeye CM
    J Microencapsul; 1997; 14(4):409-26. PubMed ID: 9229341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of the relative amounts of anhydrous carbamazepine (C15H12N2O) and carbamazepine dihydrate (C15H12N2O.2H2O) in a mixture by powder x-ray diffractometry.
    Suryanarayanan R
    Pharm Res; 1989 Dec; 6(12):1017-24. PubMed ID: 2622857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ab initio structure determination of phase II of racemic ibuprofen by X-ray powder diffraction.
    Derollez P; Dudognon E; Affouard F; Danède F; Correia NT; Descamps M
    Acta Crystallogr B; 2010 Feb; 66(Pt 1):76-80. PubMed ID: 20101086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enantioselective analysis of ibuprofen, ketoprofen and naproxen in wastewater and environmental water samples.
    Hashim NH; Khan SJ
    J Chromatogr A; 2011 Jul; 1218(29):4746-54. PubMed ID: 21645900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical aspects of dexibuprofen and racemic ibuprofen.
    Leising G; Resel R; Stelzer F; Tasch S; Lanziner A; Hantich G
    J Clin Pharmacol; 1996 Dec; 36(12 Suppl):3S-6S. PubMed ID: 9013377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Investigation of structural characteristics of initial substances of ibuprofen and micronization impact].
    Lobanov NN; Khuchua NS; Obidchenko IuA; Abramovich RA
    Antibiot Khimioter; 2012; 57(3-4):3-8. PubMed ID: 22993933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of physicochemical properties on the in vitro skin permeation of the enantiomers, racemate, and eutectics of ibuprofen for enhanced transdermal drug delivery.
    Yuan X; Capomacchia AC
    J Pharm Sci; 2013 Jun; 102(6):1957-1969. PubMed ID: 23589422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levetiracetam+nonsteroidal anti-inflammatory drug binary systems: A contribution to the development of new solid dosage forms.
    Machado SMT; Castro RAE; Maria TMR; Canotilho J; Eusébio MES
    Int J Pharm; 2017 Nov; 533(1):1-13. PubMed ID: 28893584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial salt screening procedures for manufacturing ibuprofen.
    Lee T; Wang YW
    Drug Dev Ind Pharm; 2009 May; 35(5):555-67. PubMed ID: 19005918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel X-ray powder diffractometric method for studying the reaction between pseudoephedrine enantiomers.
    Duddu SP; Khin-Khin A; Grant DJ; Suryanarayanan R
    J Pharm Sci; 1997 Mar; 86(3):340-5. PubMed ID: 9050803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a new crystalline phase of racemic Ibuprofen.
    Dudognon E; Danède F; Descamps M; Correia NT
    Pharm Res; 2008 Dec; 25(12):2853-8. PubMed ID: 18563538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calculation of the penetration depth of X-rays in intact pharmaceutical film-coated tablets by microdiffractometry.
    Yamada H; Suryanarayanan R
    Pharm Res; 2006 Sep; 23(9):2149-57. PubMed ID: 16906453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary pharmacokinetic study of ibuprofen enantiomers after administration of a new oral formulation (ibuprofen arginine) to healthy male volunteers.
    Fornasini G; Monti N; Brogin G; Gallina M; Eandi M; Persiani S; Bani M; Della Pepa C; Zara G; Strolin Benedetti M
    Chirality; 1997; 9(3):297-302. PubMed ID: 9176996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racemic species of sodium ibuprofen: characterization and polymorphic relationships.
    Zhang GG; Paspal SY; Suryanarayanan R; Grant DJ
    J Pharm Sci; 2003 Jul; 92(7):1356-66. PubMed ID: 12820140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immobilization of ibuprofen and copper-ibuprofen drugs on layered double hydroxides.
    Gordijo CR; Barbosa CA; Da Costa Ferreira AM; Constantino VR; de Oliveira Silva D
    J Pharm Sci; 2005 May; 94(5):1135-48. PubMed ID: 15793807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.